Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb 1;74(2):175-179.
doi: 10.1097/QAI.0000000000001182.

Brief Report: Informing Strategies to Build PrEP Capacity Among San Francisco Bay Area Clinicians

Affiliations

Brief Report: Informing Strategies to Build PrEP Capacity Among San Francisco Bay Area Clinicians

Oliver Bacon et al. J Acquir Immune Defic Syndr. .

Abstract

A large pool of clinicians are needed to meet the growing demand for HIV preexposure prophylaxis. We surveyed a mixed group of HIV specialists and nonspecialists in the San Francisco Bay Area to determine their attitudes toward and training needs regarding prescribing preexposure prophylaxis to persons at increased risk of HIV infection. Willingness to prescribe was associated with experience in caring for HIV-infected patients (adjusted odds ratio 4.76, 95% confidence interval: 1.43 to 15.76, P = 0.01). Desire for further training was associated with concerns about drug resistance (P = 0.04) and side effects (P = 0.04) and was more common among noninfectious disease specialists. Clinicians favored online and in-person training methods.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) Frequency of providers’ concerns about prescribing PrEP, expressed as percentage of all (n=99) providers reporting each concern. (B) Training topics requested by providers, expressed as the percentage of all providers wanting PrEP training (n=64) who requested training on each topic. **More non-ID providers than ID providers wanted training in adherence counseling (84% vs. 50%, p=0.04) and PrEP side effects and toxicities (74% vs. 17%, p=0.004).

References

    1. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–2599. - PMC - PubMed
    1. Thigpen MC, Rose CE, Paxton LA. Antiretroviral preexposure prophylaxis for HIV prevention. N Engl J Med. 2013;368(1):82–83. - PubMed
    1. Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399–410. - PMC - PubMed
    1. [Accessed April 5, 2016];Preexposure Prophylaxis for the Prevention of HIV Infection in the United States - 2014 - prepguidelines2014.pdf. http://www.cdc.gov/hiv/pdf/prepguidelines2014.pdf.
    1. [Accessed April 5, 2016];National HIV/AIDS Strategy for The United States: Updated to 2020 - nhas-update.pdf. https://www.aids.gov/federal-resources/national-hiv-aids-strategy/nhas-u....